Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

Oculis (OCS) published a notification on March 4, 2026 regarding the vesting and settlement of restricted stock units (RSUs) previously granted to a director.

Rhea-AI Summary

Oculis (OCS) published a notification on March 4, 2026 regarding the vesting and settlement of restricted stock units (RSUs) previously granted to a director. The disclosure names Arshad Khanani and references an RSU vesting event dated 28 February 2026.

Argus Mar 5 session

+0.07% close to close Open Argus

Details

News Market Reaction – OCS

In the Mar 5 session, OCS gained 0.07%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement details the vesting and settlement of RSUs previously granted to a company directo...

Analysis

This announcement details the vesting and settlement of RSUs previously granted to a company director, a routine governance event rather than a business or clinical milestone. In recent months, Oculis has reported more material catalysts, including FDA Breakthrough Therapy Designation for Privosegtor and late-stage pipeline updates that coincided with 5%+ gains. Investors tracking the story may focus more on upcoming Phase 3 DIAMOND results and execution of the PIONEER program than on this administrative disclosure.

Key Figures

RSU vesting date: 28 February 2026

RSU vesting date

28 February 2026

Vesting and settlement of RSUs previously granted to a director

Historical Context

5 past events · Latest: Feb 27

5 events

1. Feb 27

   Manager RSU vesting

   24h Move

   -2.7%

   Disclosure of RSU vesting and settlement for director Arshad Khanani.

2. Feb 18

   Manager earnout vesting

   24h Move

   -0.6%

   Notifications on vesting of earnout shares and removal of restrictions for managers.

3. Feb 17

   Executive appointment

   24h Move

   +1.0%

   Appointment of Chief Legal Officer to lead legal and governance functions.

4. Jan 08

   Pipeline showcase

   24h Move

   +5.0%

   J.P. Morgan conference presentation of late-stage ophthalmology pipeline, including Privosegtor.

5. Jan 06

   Breakthrough designation

   24h Move

   +5.8%

   FDA Breakthrough Therapy Designation for Privosegtor in optic neuritis.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

rsus, persons discharging managerial responsibilities

2 terms

rsus financial

"The attached notification relates to the vesting and settlement of RSUs previously"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

persons discharging managerial responsibilities regulatory

"Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities"

Persons Discharging Managerial Responsibilities are the key people in a company who make big decisions, like top managers or executives. Knowing who they are is important because their actions can influence the company’s success or failure, and they are often required to share information about their dealings to ensure transparency for investors and the public.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ZUG, Switzerland, March 04, 2026 (GLOBE NEWSWIRE) -- The attached notification relates to the vesting and settlement of RSUs previously granted to a director of the Company.

Attachment

• Notification of managers' transaction - Arshad Khanani - 28 February 2026 RSU vest

FAQ

What did Oculis (OCS) disclose about Arshad Khanani on March 4, 2026?

Oculis disclosed the vesting and settlement of RSUs previously granted to director Arshad Khanani. According to the company, the notification references an RSU vest event dated 28 February 2026 and confirms the managerial transaction disclosure on March 4, 2026.

When did the RSUs for Arshad Khanani vest according to Oculis (OCS)?

The RSUs vested on 28 February 2026, as referenced in the company's notification. According to the company, the disclosure relates specifically to the vesting and settlement of those previously granted restricted stock units to the director.

Does the Oculis (OCS) notification indicate any cash proceeds or sale by the director?

No cash proceeds or share sale details are disclosed in the notification about the RSU vesting. According to the company, the announcement only covers vesting and settlement of RSUs and does not state any subsequent sales or cash transactions.

Which corporate action did Oculis (OCS) report on March 4, 2026 for insiders?

Oculis reported a managers' transaction notification regarding RSU vesting and settlement for a director. According to the company, the filing documents the administrative vesting event dated 28 February 2026 involving Arshad Khanani.

How should investors interpret the Oculis (OCS) RSU notification dated March 4, 2026?

The notification is an insider disclosure of RSU vesting, not operational or financial guidance. According to the company, it records the vesting and settlement event for a director on 28 February 2026 and offers transparency on managerial transactions.